Julien Racle - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Julien Racle

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Biotechnology|October 11, 2024

A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.

Science Translational Medicine|April 13, 2018

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.

Nature Communications|September 21, 2017

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axisSara Trabanelli, Mathieu F Chevalier, Amaia Martinez-Usatorre, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Biotechnology|October 11, 2024

A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.

Science Translational Medicine|April 13, 2018

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.

Nature Communications|September 21, 2017

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axisSara Trabanelli, Mathieu F Chevalier, Amaia Martinez-Usatorre, et al.

Pageof 4